AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2020
Aug 21, 2020
34229_dirs_2020-08-21_8a9b4360-7942-49d1-804b-b65c71ebc767.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2020-08-17
Reporting Person: HAN QUEENA (VP Finance & HR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-17 | Common Shares | M | 1300 | $7.50 | Acquired | 1300 | Direct |
| 2020-08-17 | Common Stock | S | 1300 | $19.30 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-17 | Stock options | $7.50 | M | 1300 | Disposed | 2021-02-28 | Common Stocks (1300) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12